HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by MacRae, A. R. Articles by Lepage, N. Search for Related Content PubMed PubMed Citation Articles by MacRae, A. R. Articles by Lepage, N. Related Collections General Clinical Chemistry Pediatric Clinical Chemistry Evidence Based Laboratory Medicine and Test Utilization Endocrinology and Metabolism

Outcome Validation of the Beckman Coulter Access Analyzer in a Second-Trimester Down Syndrome Serum Screening Application

¹ The Research Institute at Lakeridge Health Inc., 850 Champlain Ave., Oshawa, Ontario, L1J 8R2 Canada.

² Genetic Services, Lakeridge Health Corporation, 1 Hospital Ct., Oshawa, Ontario, L1G 2B9 Canada.

³ Clinical Biochemistry, The Toronto Hospital, 200 Elizabeth St., Toronto, Ontario, M5G 2C4 Canada.

⁴ Department of Clinical Biochemistry, London Health Sciences Centre, 375 South St., London, Ontario, N6A 4G5 Canada.

⁵ Department of Biochemistry, Children’s Hospital of Eastern Ontario, 401 Smyth Rd., Ottawa, Ontario, K1H 8L1 Canada.

^aAuthor for correspondence.

Background: Mid-trimester maternal serum -fetoprotein (AFP) and unconjugated estriol (uE3) are 30% lower and human chorionic gonadotropin (hCG) is twofold higher in Down syndrome pregnancies compared with unaffected pregnancies. In maternal serum screening, patient-specific risks are calculated using published gaussian frequency distribution parameters for these three markers obtained with previously available immunoassays. New immunoassays must generate similar distribution parameters if the accuracy of assigned risks and overall performance of prenatal screening are to be maintained.

Methods: Agreement between the Beckman Coulter Access and the Bayer Immuno 1 assays for AFP and hCG and the Amersham Amerlex-M RIA for uE3 was assessed in 558 fresh sera. Precision was measured over 6 weeks. Median concentrations were calculated by regression of 568 Caucasian singleton pregnancy samples against gestational age in days. Frozen mid-trimester sera from 44 confirmed Down syndrome singleton pregnancies (cases) were selected without conscious bias for reanalysis, and each case was matched with five control specimens from unaffected pregnancies. Serum markers were expressed as the multiple of the median (MoM) concentration derived from the control samples, cor-rected for maternal weight and converted to their log-equivalent values. Normality was assessed using probability plots and the Shapiro–Wilk W-test. Gaussian distribution parameters were compared with established values, and Down syndrome risk calculations were assessed with a commonly used risk algorithm.

Results: The Access AFP and hCG assays had consistent proportional agreement with the established assays, whereas agreement between the uE3 methods was less consistent. Analytical imprecision was 3–6% at mid-trimester concentrations. Normal distributions were obtained for the log MoM values of all three markers in both the Down syndrome and unaffected populations, and their gaussian distribution parameters compared well with established values. The performance of the Access assays in an established trivariate risk algorithm for Down syndrome was equal to the performance exhibited by traditional methods.

Conclusion: The Beckman Coulter Access analyzer provides valid mid-trimester serum AFP, uE3, and hCG results and risk assessments when applied in a prenatal Down syndrome screening service.

The following articles in journals at HighWire Press have cited this article:

				G Vranken, T Reynolds, and J Van Nueten Medians for second-trimester maternal serum markers: geographical differences and variation caused by median multiples-of-median equations. J. Clin. Pathol., June 1, 2006; 59(6): 639 - 644. [Abstract] [Full Text] [PDF]